Remove Clinical Development Remove Nurses Remove RNA
article thumbnail

?5 Things You Need to Know from Our Recent Gene Therapy Webinar

Worldwide Clinical Trials

We’ve also seen a decrease in available research nurses, as they have had to be reassigned to COVID patients. It really is—there has been a 10x increase in cell and gene therapies in the clinical development pipeline since 2012. Fewer staff creates many problems, including less bandwidth to meet for reviews and approvals.

article thumbnail

How Can You Manage the Complexity of Early Phase Clinical Development?

XTalks

Oren Cohen, MD, FIDSA CMO & President of Clinical Pharmacology Fortrea Fortrea is a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, market access solutions and other enabling services. They are unique and require specific expertise.” FIH studies involve a lot of risk.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

The company’s candidate vaccine, mRNA-1273, is a synthetic messenger RNA that encodes the stabilized SARS-CoV-2 spike protein. That said, the percentage of all COVID-19 deaths that occurred in nursing homes, standing at 81 percent, is the highest in the world followed by Spain at 66 percent.